Fedra Palazuelos-Irazoque

Instituto De Seguridad Y Servicios Sociales De Los Trabajadores Del Estado, GUA, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Response to the letter to the editor: "Latent tuberculosis in rheumatologic patients under biological therapy: Methodological considerations and a primary care perspective".

Response to the letter to the editor: "Latent tuberculosis in rheumatologic patients under biological therapy: Methodological considerations and a primary care perspective".

Journal: Reumatologia clinica

Published: May 05, 2026

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.

Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.

Journal: The New England journal of medicine

Published: March 06, 2026

Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX: Erratum.

Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX: Erratum.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: February 23, 2026

Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX.

Clinical Characteristics and 1-Year Response in Rheumatic Mexican Patients Using JAK Inhibitors: Data From BIOBADAMEX.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: August 15, 2025

Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registry.

Prevalence of latent tuberculosis in patients with rheumatological diseases exposed to biologic drugs and small molecules: A study based on the BIOBADAMEX national registry.

Journal: Reumatologia clinica

Published: August 01, 2025

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Journal: The New England journal of medicine

Published: February 10, 2025

Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX Cohort.

Differences in Clinical Profiles and Biologic Treatment Approaches for Autoimmune Rheumatic Diseases Across Regions in Mexico: An Analysis of the BIOBADAMEX Cohort.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: January 06, 2025

Lupus nephritis in Mexican patients: Response to intensive therapy.

Lupus nephritis in Mexican patients: Response to intensive therapy.

Journal: Reumatologia clinica

Published: December 24, 2024

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Clinical Practice Mexican Guidelines for the Treatment of Systemic Lupus Erythematosus: 2024 Update.

Journal: Reumatologia clinica

Published: June 21, 2024

High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.

High Mortality of COVID-19 in Young Mexican Patients With Rheumatic Diseases: Comparative Analysis Versus the General Population.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: May 16, 2024

Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil.

Socioeconomic factors and COVID-19 mortality in immune-mediated rheumatic diseases patients: regional analysis from Argentina, Mexico and Brazil.

Journal: Advances in rheumatology (London, England)

Published: May 02, 2024

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023.

Journal: Reumatologia clinica

Published: January 25, 2024

Showing 1-12 of 26

Last Updated: 09/26/2026